Does PALBOCICLIB Cause Therapy change? 204 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 204 reports of Therapy change have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
204
Reports of Therapy change with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
0
Deaths
18
Hospitalizations
How Dangerous Is Therapy change From PALBOCICLIB?
Of the 204 reports, 18 (8.8%) required hospitalization.
Is Therapy change Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 204 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Therapy change?
MACITENTAN (346)
SELEXIPAG (285)
EPOPROSTENOL (237)
LENALIDOMIDE (212)
CAPECITABINE (200)
TREPROSTINIL (189)
GLATIRAMER (184)
AMBRISENTAN (143)
ADALIMUMAB (139)
HUMAN IMMUNOGLOBULIN G (129)
Which PALBOCICLIB Alternatives Have Lower Therapy change Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID